, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

up 21.80 %

Autodesk, Inc. (ADSK) upgraded to Outperform with price target $46 by Robert W. Baird

Posted on: Monday,  Mar 21, 2011  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Autodesk, Inc. (NASDAQ: ADSK) on 03/21/2011, when the stock price was $41.05. Since
then, Autodesk, Inc. has gained 21.80% as of 11/20/2015's recent price of $50.00.
If you would have followed this Robert W. Baird's recommendation on ADSK, you would have gained 21.8% of your investment in 1705 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/21/2011 8:25 AM Buy
41.05 46.00
as of 12/30/2011
1 Week down  -1.55 %
1 Month down  -10.97 %
3 Months up  9.13 %
1 YTD down  -26.11 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/21/2008 8:25 AM Hold
12.84 20.00
10/10/2007 9:25 AM Buy
50.79 57.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy